News
Broad Institute will retain CRISPR patents, ruling says
The Broad Institute in Cambridge, Massachusetts, will retain potentially lucrative rights to a powerful gene-editing technique that could lead to major advances in medicine and agriculture, the federal Patent and Trademark Office ruled Wednesday.